Status:
COMPLETED
Percutaneous Lung Biopsy Using Cone Beam CT With Virtual Guidance: a Randomized Control Trial
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Image-guided percutaneous lung biopsy is an essential procedure in lung cancer management, where it is integral to confirming the diagnosis and determining tumour histology. An ideal percutaneous lung...
Detailed Description
Image-guided percutaneous lung biopsy is an essential procedure in lung cancer management, where it is integral to confirming the diagnosis and determining tumour histology. In this era of personalize...
Eligibility Criteria
Inclusion
- Solitary or multiple lung lesions (solid or subsolid nodule, pulmonary infiltrate) ≥1cm
Exclusion
- Patient \<18 years old
- Patient not able to give informed consent
- Uncooperative patient who is unable to hold still or hold their breath for safe biopsy
- Lesions \<1cm
- Lesions within 1cm of vital thoracic structures such as the great vessels and the mediastinum
- Peripheral lesions accessible to biopsy with ultrasound guidance
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 22 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04299542
Start Date
May 4 2020
End Date
November 22 2021
Last Update
October 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong, Hong Kong